Daniel J. Anderson
60 works · 6,785 citations · h-index 23
Top works
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
- Reshaping of the endoplasmic reticulum limits the rate for nuclear envelope formation
- Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum
- Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
- Nuclear Pores Form de Novo from Both Sides of the Nuclear Envelope
- Transient nuclear envelope rupturing during interphase in human cancer cells
- Cik1 Targets the Minus-End Kinesin Depolymerase Kar3 to Microtubule Plus Ends
- Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)
- Crystal structure of the proteasomal deubiquitylation module Rpn8-Rpn11
- Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo
- Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo
- The life cycle of the metazoan nuclear envelope
- Shaping the endoplasmic reticulum into the nuclear envelope
- The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma